0
Aligos Therapeutics, Inc. Banner Image

Aligos Therapeutics, Inc.

  • Ticker ALGS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aligos Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral diseases. Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver and viral diseases to discover and develop potentially best in class therapeutics for nonalcoholicMore steatohepatitis (NASH) and viruses with high unmet medical need such as coronaviruses and chronic hepatitis B (CHB).
REPORT RATINGS
3.5 / 5.0 (4)

Aligos Therapeutics, Inc. reports have an aggregate usefulness score of 3.5 based on 4 reviews.

Aligos Therapeutics, Inc.

Most Recent Annual Report

Aligos Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Aligos Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!